Press Releases

ST. LOUIS, Nov. 15, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has commenced an offering to sell $7,000,000,000 of senior notes. The $7,000,000,000 of senior notes will include an add-on to its 5.375% senior notes due 2026 (the "2026 Notes"), new sen

BRUSSELS, Nov. 15, 2019 /PRNewswire/ -- Regulated Information – Inside Information – UCB, a global biopharmaceutical company, today announced positive results from BE READY, the second of three Phase 3 studies this year to report findings on the investigational treatment bimekizumab.1 BE READY evaluated the efficacy and safety of

BILLERICA, Mass., Nov. 15, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:

DUBLIN, Nov. 15, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the marketing authorisation of solriamfetol to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with narcoleps

WASHINGTON, Nov. 15, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista completed its initial public offering (IPO) in September 2019, with Danaher retaining an 80.6 percent o

BREA, Calif., Nov. 15, 2019 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced it intends to file a Form S-4/S-1 Registration Statement today with the Securities and Exchange Commission (SEC) in connection with Danaher's (NYSE: DHR) proposed offer to exchange shares of Envista common stock it owns for shares of Danaher common stock. In the offer, Danaher

IRVINE, Calif., Nov. 15, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it appointed Michael DiTolla, DDS, FAGD to its board of directors, effective November 14, 2019. The appointment increases the size of the BIOLASE Board of Directors to seven membe

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced that it will present data from an ongoing Phase 1/2 clinical trial entitled "A Phase 1/2 Study in Patients with Solid Tumors Ha

LOS ANGELES, Nov. 15, 2019 /PRNewswire/ -- The lyrics are powerful, the message is clear, the visuals tell a story even with your volume silenced. Ethan Sak captivates a global audience with his ability to interpret an unfortunate relatable experience by turning it into a colorful visual with a universal language. Many artists steer away fr

OSLO, Norway, Nov. 15, 2019 /PRNewswire/ --  Nordic Nanovector ASA (OSE: NANO) announces that members of its senior management team will participate and present at the following upcoming investor conferences during November and December   Jefferies Healthcare Conference in London on 21 November